People · Operator

Martin J. Madaus

Named in public records as an officer, director or promoter · active 2012–2012 · Pharmaceuticals

1
Companies
1
Filings
$1.3M
Combined raised · real
Single
Operator type
Companies
CompanyRoleSectorStageRaised · realValue · estTied
Jaguar Holding Co IPharmaceuticalsSeed$1.3M$47.6M2012
Operator network

Martin J. Madaus at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.

B. Judd Hartman · 3 companies · 1 sharedB. Judd HartmanDaniel G. Darazsdi · 2 companies · 1 sharedDaniel G. DarazsdiJeffrey J. Kindler · 2 companies · 1 sharedJeffrey J. KindlerP Hunter Philbrick · 2 companies · 1 sharedP Hunter PhilbrickStephen H. Wise · 2 companies · 1 sharedStephen H. WiseWilliam J. Sharbaugh · 2 companies · 1 sharedWilliam J. Sharba…Allen Hunter Thorpe · 1 companies · 1 sharedAllen Hunter Thor…Brian G. Tuttle · 1 companies · 1 sharedBrian G. TuttleCharles Hunter Rozwat · 1 companies · 1 sharedCharles Hunter Ro…David Simmons · 1 companies · 1 sharedDavid SimmonsKaren Hunter Bechtel · 1 companies · 1 sharedKaren Hunter Bech…Peter J. Clare · 1 companies · 1 sharedPeter J. ClareRobert J. Essner · 1 companies · 1 sharedRobert J. EssnerJaguar Holding Co I · $1.3M raisedJaguar Holding Co IMartin J. MadausMM
Martin J. Madaus Company Co-operator (ring = serial)Hover to isolate ties · click to open
Co-operators (shared boards)

People named alongside Martin J. Madaus on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.

OperatorSharedTheir companies
B. Judd Hartman13
Stephen H. Wise12
Daniel G. Darazsdi12
William J. Sharbaugh12
P Hunter Philbrick12
Jeffrey J. Kindler12
David Simmons11
Brian G. Tuttle11
Allen Hunter Thorpe11
Peter J. Clare11
Charles Hunter Rozwat11
Karen Hunter Bechtel11
Robert J. Essner11

People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.